HighVista Strategies’s GH Research GHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3M Sell
213,212
-27,312
-11% -$419K 0.83% 36
2025
Q4
$3.05M Sell
240,524
-1,370
-0.6% -$18.7K 0.79% 40
2025
Q3
$3.46M Buy
241,894
+189,647
+363% +$2.65M 0.85% 32
2025
Q2
$637K Buy
+52,247
New +$573K 0.23% 119
2023
Q1
Sell
-65,597
Closed -$638K 119
2022
Q4
$638K Buy
65,597
+8,828
+16% +$95.5K 0.38% 69
2022
Q3
$660K Sell
56,769
-7,167
-11% -$90.4K 0.38% 72
2022
Q2
$638K Buy
63,936
+11,096
+21% +$144K 0.39% 63
2022
Q1
$966K Buy
52,840
+25,830
+96% +$456K 0.61% 37
2021
Q4
$630K Buy
+27,010
New +$593K 0.5% 61

Other funds holding GHRS

HighVista Strategies's GHRS Position: Q1 2026 in Review

HighVista Strategies reduced its GH Research (GHRS) stake by 11% in Q1 2026, selling an estimated $419K and leaving 213,212 shares worth $3M. The position accounts for 0.83% of the portfolio, ranked #36.

HighVista Strategies first reported a position in GHRS in Q4 2021 and has held it in 9 quarters since. The position peaked at $3.46M in Q3 2025. 54 funds tracked by Wall St. Rank hold GHRS as of Q1 2026.

  • HighVista Strategies held 213,212 shares of GH Research worth $3M as of Q1 2026.
  • HighVista Strategies sold 27,312 GH Research shares in Q1 2026, an estimated $419K.
  • GH Research made up 0.83% of HighVista Strategies's portfolio in Q1 2026, its #36 holding.
  • HighVista Strategies first reported a position in GH Research in Q4 2021 and has held it in 9 quarters since.
  • HighVista Strategies's GH Research position peaked at $3.46M in Q3 2025.
  • 54 funds tracked by Wall St. Rank held GH Research as of Q1 2026.

Based on HighVista Strategies's 13F filing for Q1 2026, filed 15 May 2026.